XML 37 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2016
Components of Derivative Liabilities

The following tables summarize the components of our derivative liabilities and linked common shares as of September 30, 2016 and December 31, 2015 and the amounts that were reflected in our income related to our derivatives for the periods then ended:

 

     September 30,      December 31,  
     2016      2015  

Derivative liabilities:

     

Embedded derivatives derived from:

     

2014 Convertible Promissory Notes

   $ —        $ 3,396,191  
  

 

 

    

 

 

 
     —          3,396,191  

Warrant derivatives

     

Senior Convertible Notes

     142        6,225  
  

 

 

    

 

 

 

Warrant derivatives

     142        6,225  
  

 

 

    

 

 

 

Total derivative liabilities

   $ 142      $ 3,402,416  
  

 

 

    

 

 

 

 

     September 30,      December 31,  
     2016      2015  

Common shares linked to derivative liabilities:

     

Embedded derivatives:

     

2014 Convertible Promissory Notes*

     —          3,174,604  
  

 

 

    

 

 

 
     —          3,174,604  
  

 

 

    

 

 

 

Warrant derivatives

     

Senior Convertible Notes

     130,208        130,208  
  

 

 

    

 

 

 
     130,208        130,208  
  

 

 

    

 

 

 

Total common shares linked to derivative liabilities

     130,208        3,304,812  
  

 

 

    

 

 

 

 

* The common shares indexed to the 2014 Convertible Promissory Notes are shares indexed to Oceanica.
Changes in Fair Values of Derivative Liabilities
     Three months ended September 30,      Nine months ended September 30,  
     2016      2015      2016      2015  

Derivative income (expense):

           

Unrealized gains (losses) from fair value changes:

           

Senior Convertible Notes

   $ —         $ —         $ —         $ —     

2014 Convertible Promissory Notes

     —           (18,889      1,939,366         (350,873

Warrant derivatives

     3,748         14,157        6,082         95,128  
  

 

 

    

 

 

    

 

 

    

 

 

 
     3,748         (4,732      1,945,448         (255,745

Redemptions of Senior Convertible Notes

     —           —           1,456,825         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total derivative income (expense)

   $ 3,748       $ (4,732    $ 3,402,273       $ (255,745
  

 

 

    

 

 

    

 

 

    

 

 

 
2014 Share Purchase Option [Member]  
Changes in Fair Value Inputs and Assumptions

The following table reflects the issuances of the Share Purchase Option derivatives and changes in fair value inputs and assumptions for these derivatives during the nine months ended September 30, 2016 and 2015.

 

    

For the nine months ended

September 30,

 
     2016      2015  

Balances at January 1

   $ 3,396,191      $ 2,115,318  

Issuances

     —          —    

Modification

     (1,456,826      —    

Changes in fair value inputs and assumptions reflected in income

     (1,939,365      350,873  
  

 

 

    

 

 

 

Balances at September 30

   $ —        $ 2,466,191  
  

 

 

    

 

 

 
Senior Convertible Notes [Member]  
Significant Assumptions Utilized in Valuation Technique

Significant inputs and results arising from the Monte Carlo Simulations process are as follows for the share purchase options that have been bifurcated from our Monaco Notes and classified in liabilities as of March 8, 2016 (Modification Date), December 31, 2015, and the inception dates (Tranche 1 – August 14, 2014, Tranche 2 – October 1, 2014, Tranche 3 – December 1, 2014):

 

Tranche 1 – August 14, 2014:

   March 8, 2016***   December 31, 2015   August 14, 2014

Underlying price on valuation date*

   $1.25   $2.50   $2.50

Contractual conversion rate

   $3.15   $3.15   $3.15

Contractual term to maturity**

   1.82 Years   2.00 Years   2.00 Years

Implied expected term to maturity

   1.24 Years   1.82 Years   1.85 Years

Market volatility:

      

Range of volatilities

   96.0% - 154.0%   85.2% - 109.8%   37.0% - 62.2%

Equivalent volatilities

   120.1%   98.1%   51.2%

Contractual interest rate

   11.00%   11.00%   8.0% - 11.0%

Equivalent market risk adjusted interest rates

   11.60%   11.00%   9.50%

Range of credit risk adjusted yields

   3.49% - 5.02%   3.29% - 4.22%   3.94% - 4.45%

Equivalent credit risk adjusted yield

   4.13%   3.76%   4.15%

Tranche 2 – October 1, 2014:

   March 8, 2016***   December 31, 2015   October 1, 2014

Underlying price on valuation date*

   $1.25   $2.50   $2.50

Contractual conversion rate

   $3.15   $3.15   $3.15

Contractual term to maturity**

   1.82 Years   2.00 Years   2.00 Years

Implied expected term to maturity

   1.24 Years   1.82 Years   1.79 Years

Market volatility:

      

Range of volatilities

   96.0% - 154.0%   85.2% - 109.8%   58.6% - 75.3%

Equivalent volatilities

   120.1%   98.1%   68.00%

Contractual interest rate

   11.00%   11.00%   8.0% - 11.0%

Equivalent market risk adjusted interest rates

   11.60%   11.00%   9.25%

Range of credit risk adjusted yields

   3.49% - 5.02%   3.29% - 4.22%   3.97% - 4.61%

Equivalent credit risk adjusted yield

   4.13%   3.76%   4.24%

Tranche 3 – December 1, 2014:

   March 8, 2016***   December 31, 2015   December 1, 2014

Underlying price on valuation date*

   $1.25   $2.50   $2.50

Contractual conversion rate

   $3.15   $3.15   $3.15

Contractual term to maturity**

   1.82 Years   2.00 Years   2.00 Years

Implied expected term to maturity

   1.24 Years   1.82 Years   1.76 Years

Market volatility:

      

Range of volatilities

   96.0% - 154.0%   85.2% - 109.8%   61.8% - 79.8%

Equivalent volatilities

   120.1%   98.1%   72.2%

Contractual interest rate

   11.00%   11.00%   8.0% - 11.0%

Equivalent market risk adjusted interest rates

   11.60%   11.00%   9.25%

Range of credit risk adjusted yields

   3.49% - 5.02%   3.29% - 4.22%   4.29% - 4.84%

Equivalent credit risk adjusted yield

   4.13%   3.76%   4.52%

 

* The instrument is convertible into shares of the Company’s subsidiary, Oceanica, which is not a publicly-traded entity. Therefore, its shares do not trade on a public exchange. As a result, the underlying value was originally based on private sales of the subsidiary’s shares because that was the best indicator of the value of the shares in the past. The last sale of Oceanica’s shares in which a private investor accumulated 24% of the shares of which their last purchase price was for $2.50 per share in December 2013. Accordingly, the underlying price used in the past in the MCS calculations was the $2.50 for the inception dates and December 31, 2015. Being far removed from December 2013 while considering the modification in March 2016 of the new option price of $1.00 and other market conditions currently prevailing, management determined $1.25 to be fairly representative of the per share fair value.
** On December 10, 2015 the term was extended to December 31, 2017.

In March 2016 the term was extended to March 8, 2018.

 

*** In March 2016 the purchase price of the share purchase options was modified to $1.00 per share. As a result of the re-pricing, the share purchase options no longer require measurement as derivative liabilities. The MCS were calculated for the instruments just prior to the modification on March 8, 2016.
Warrant Derivatives [Member]  
Significant Assumptions Utilized in Valuation Technique

Significant assumptions and utilized in the Binomial Lattice process are as follows for the warrants linked to 130,208 shares of common stock as of September 30, 2016 and December 31, 2015:

 

     September 30,   December 31,
     2016   2015

Linked common shares

   130,208   130,208

Quoted market price on valuation date

   $3.59   $3.24

Contractual exercise price

   $43.20   $43.20

Term (years)

   0.60   1.35

Range of market volatilities

   29.9% - 158.8%   92.9% - 113.2%

Risk free rates using zero coupon US Treasury Security rates

   0.20% - 0.45%   0.16% - 0.65%
Changes in Fair Value Inputs and Assumptions

The following table reflects the issuances of derivative warrants and changes in fair value inputs and assumptions related to the derivative warrants during the nine months ended September 30, 2016 and 2015.

 

     Nine months ended September 30,  
     2016      2015  

Balances at January 1

   $ 6,225      $ 111,127  

Changes in fair value inputs and assumptions reflected in income

     (6,083      (95,128
  

 

 

    

 

 

 

Balances at September 30

   $ 142      $ 15,999